ide dismutase (ECSOD) by chondrocytes, affecting the level of antioxidant protection in joint tissue. Methods: Human cartilage explant cultures and primary monolayer cultures were used to assess the secretion of ECSOD in basal state and in response to IL-1 beta, with and without IL-1 receptor antagonist. ECSOD secretion was measured with an ELISA. Simultaneous determinations of nitrc oxide production were made using the greiss method. Results: IL-1beta decreases secretion of EC-SOD from chondrocytes both in explant and monolayer culture and treatment with both IL-1beta and IL-1 receptor antagonist together restores ECSOD secretion. As previously shown we find that IL-1 increases nitric oxide while treatment with IL-1 receptor antagonist reduces nitric oxide production. Conclusions: ECSOD scavenges superoxide and prevents oxidative damage in the joint. Cartilage tissue generates reactive oxygen species in response to cytokines and mechanical forces leaving the tissue vulnerable to oxidative damage. Chronic oxidative stress may increase cell senescence, cause damage to structural matrix proteins and alter cell signaling pathways leading to osteoarthritis. The finding that a key inflammatory cytokine (IL-1) decreases the available antioxidant protection in the joint may explain the progressive joint damage after inflammatory pathways are activated. Purpose: The aim of this study was to investigate if addition of bone morphogenetic protein (BMP)-2 to human articular chondrocytes (HACs) could help to maintain their chondrogenic phenotype in long-term culture conditions necessary for autologous chondrocyte implantation (ACI). We also evaluated the potential of BMP-2 as a repair factor in combination with collagen-based biomaterials, to extend the technique to osteoarthritic lesions. Methods and Material: In a first step, HACs from 19 donors were cultured independently, according to the procedure used for ACI. Real-time PCR and Western blotting were used to evaluate the chondrocyte phenotype and gel retardation assays were performed to analyze DNA binding of transcription factors under the effect of BMP-2. Next, we evaluated the responsiveness of HAC to BMP-2 when cultured within collagen sponges. This first approach was undertaken with independent cultures of three donors and the cellular phenotype was estimated by using real-time PCR. Results: Exogenous BMP-2 improved the chondrogenic character of HACs when amplified over two passages in monolayer. The stimulatory effect of BMP-2 on type II collagen expression was observed not only at the mRNA level but also at the protein level, and this is crucial for cartilage matrix reconstruction. Our preliminary data with HACs first amplified in monolayer then cultured in collagen sponges in the presence of BMP-2 have revealed that BMP-2 is able to restore COL2A1 gene expression that was lost during the amplification step. Conclusions: Adding exogenous BMP-2 to HACs expanded in the conditions generally used for ACI or during Matrix-associated ACI is clearly beneficial to support the chondrocytic phenotype. Importantly, no sign of hypertrophic maturation or osteogenic induction was detected beside the chondrogenic stimulatory effect of BMP-2. This study is the first to reveal the benefit of adding exogenous BMP-2 to HACs as a therapeutic agent for cartilage repair. Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condition re-sulting from lack of homogentisate 1,2 dioxygenase (HGD), the enzyme responsible for the breakdown of homogentisic acid (HGA). HGA accumulates in body tissues resulting in ochronosis, the deposition of pigmented polymers in collagenous tissues, primarily the articular cartilage of the weight bearing joints. Over time, ochronosis leads to severe, early onset joint degeneration presenting clinically as osteoarthritis. The aim of this study was to use light and scanning electron microscopy (SEM) to elucidate the initiation and progression of pigmentation and the consequent osteoarthropathy in AKU. Methods: Tissues were collected from patients undergoing joint replacement surgery for alkaptonuric osteoarthropathy (n=14). Samples were processed as follows:-histology to identify pigment deposition, topographical 3D SEM to observe the trabecular bone network and quantitative back scattered electron SEM (qBSE-SEM) to determine the mineral content of cartilage and bone. Results: Histological examination of articular cartilage revealed significant variation in the extent of pigmentation between samples, and regionally within samples. Initial pigmentation was associated with single chondrocytes near the tidemark and was present intracellularly, and in the lacunae and territorial matrix. From there, deposition of pigment progressed to the interterritorial matrix in the deep zones and then towards the articular surface. Once the hyaline cartilage became extensively pigmented, there was aggressive remodeling of the calcified cartilage and underlying bone. Eventually this led to complete loss of the subchondral plate leaving non-calcified, pigmented hyaline cartilage in contact with the trabecular bone network. In addition, poorly or non-mineralised bone was present in the trabecular network in closest proximity to the pigmented hyaline articular cartilage. Pigmentation was not detected in mineralised bone matrix, however osteocytes, osteoclasts and osteoblasts all displayed intracellular pigmentation, along with the canalicular network and osteocyte lacunae.
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Osteoclasts were also seen phagocytosing pigmented osteocytes. Conclusions: Calcified cartilage and subchondral bone appear to play key roles in the pathogenesis of osteoarthropathy in AKU. Our findings indicate that cartilage matrix is initially protected from ochronosis. Early pigmentation occurs deep in the cartilage, possibly in response to mechanical or biochemical injury. HGA thus appears to be an endogenous marker of osteoarthritic changes. Once the initial pigment is deposited, the biomechanical and functional properties of cartilage are further altered leading to additional damage, more pigmentation and a downward spiral of tissue destruction producing a more rapid, severe and earlier onset of osteoarthropathy than is seen in typical OA. Extreme phenotypes in monogenic diseases can help elucidate the molecular pathogenesis of more common disorders. We believe that the initiation and rapid progression of ochronosis and in osteoarthropathy in AKU may also help elucidate the molecular pathology of OA. Figure 1 ).
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EXPRESSION OF TRANSIENT RECEPTOR POTENTIAL VANILLOID (TRPV) CHANNELS IN DIFFERENT PASSAGES OF EQUINE ARTICULAR CHONDROCYTES
Figure 1
Conclusions: This study confirmed the presence of TRPV4, TRPV5 and TRPV6 in equine articular chondrocytes up to passage 3. Furthermore, the TRPV5 and TRPV6 were upregulated with time and cell passage in culture suggesting that a shift in the phenotype of the cells in monolayer culture can alter the expression of these channels. The results presented suggest that several TRPV channels may be involved in calcium signalling and homeostasis in chondrocytes. A better understanding of the interactions between calcium, TRPV channels and mechanical or osmotic changes in the joint will hopefully provide new insights into cartilage mechanotransduction and the pathophysiology of osteoarthritis. Purpose: Glucocorticoids are beneficial in the treatment of inflammatory and immune disorders, but have also been shown to protect cartilage when treating for osteoarthritis. Unfortunately, prolonged glucocorticoid therapy, in high doses, has been associated with bone loss, resulting in severe osteoporosis. These conflicting effects by glucocorticoids on bone and cartilage may result from a miscommunication between the bone and cartilage cells. We investigated the effect of the glucocorticoid, prednisolone, in an ex vivo murine femoral head model, which allowed the interactions between osteoblasts, osteoclasts and chondrocytes. Methods: Femoral heads from 12-week-old female mice were isolated and cultured for 21 days in serum-free media in the absence or presence of prednisolone [10 uM], OSM [10 ng/ml] + TNF-α [20 ng/ml]
PREDNISOLONE INDUCES A CATABOLIC EFFECT ON BONE FORMATION; BUT INHIBITS CYTOKINE-INDUCED CARTILAGE DEGRADATION AND
